Tauvid: Clinical Trials

10 trials of Tauvid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 enrolling by invitation, 1 terminated. 7 Phase 1, 1 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 6, Terminated 1
Early Phase 11Completed 1
Phase 21Completed 1

Follow Tauvid: new trials by email Literature Review of Tauvid trials Research Report on Tauvid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Alzheimer's Disease Neuroimaging Initiative 4
Neuraceq, Amyvid, Tauvid - Mild Cognitive Impairment, Alzheimer Disease
Enrolling by invitationUniversity of Southern California15002023-06-092026-09-29
Flortaucipir PET Imaging in Subjects With FTD
Flortaucipir F18, Brain PET scan - Frontotemporal Dementia
Phase 1CompletedAvid Radiopharmaceuticals162017-04-112020-09-25
Flortaucipir 18F PET Imaging in BIOCARD Study
Flortaucipir F18, Brain PET scan - Cognitive Decline
Phase 1TerminatedAvid Radiopharmaceuticals232017-03-232020-09-25
Tau Imaging in Professional Fighters
Flortaucipir F18, Brain PET scan - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals352015-02-182020-09-10
Augmenting Flortaucipir Dosimetry Estimates
Flortaucipir F18 - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals62015-01-012020-08-11
Clinical Evaluation of Flortaucipir F 18
Flortaucipir F18, Brain PET scan - Alzheimer's Disease, Traumatic Brain Injury
Phase 2CompletedAvid Radiopharmaceuticals1792014-12-012020-09-10
Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease
Flortaucipir F18, Brain PET scan - Alzheimer Disease, Mild Cognitive Impairment
Phase 1CompletedAvid Radiopharmaceuticals892014-10-012020-09-25
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Flortaucipir F18, Brain PET scan - Progressive Supranuclear Palsy, Corticobasal Degeneration
Phase 1CompletedAvid Radiopharmaceuticals292014-08-122020-08-28
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
Flortaucipir F18, Brain PET scan - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals242013-11-132020-09-07
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects
Flortaucipir F18, Brain PET Scan, Whole body PET scan - Alzheimer Disease
Early Phase 1CompletedAvid Radiopharmaceuticals362013-08-162020-09-25

Conditions studied

Alzheimer Disease (7)  ·  Cognitive Dysfunction (3)  ·  Brain Injuries, Traumatic (1)  ·  Cognition Disorders (1)  ·  Corticobasal Degeneration (1)  ·  Dementia (1)  ·  Depression (1)  ·  Frontotemporal Dementia (1)  ·  Pick Disease of the Brain (1)  ·  Plaque, Amyloid (1)  ·  Supranuclear Palsy, Progressive (1)

Sponsors

Avid Radiopharmaceuticals (9)  ·  University of Southern California (1)

Countries

United States (9)  ·  Canada (1)

Top investigators

Michael Weiner, MD (1)  ·  Paul Aisen, MD (1)  ·  Ronald Petersen, MD, PHD (1)

Results publications

PMID 29284675, PMID 33141172, PMID 42467182

NIH funding

U19AG024904 (1)